About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Michigan | 20,100 Studies Near You

Clinical TrialsMichigan

Clinical Trials in Michigan

Discover 20,100 clinical trials near Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 3341-3360 of 20,100 trials

CompletedPilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 SyndromePilot study into low dose naltrexone (LDN) and NAD+ for treatment of patients with post-COVID-19 syndrome.NCT04604704·Ann Arbor, Michigan CompletedS1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory MyelomaThis randomized phase II trial compares how well two different doses of carfilzomib work when given with dexamethasone in treating patients with multiple myeloma that has come…NCT01903811·Fairbanks, Alaska and 484 others

Find Trials by Condition in Michigan

Breast Cancerin Michigan Lung Cancerin Michigan Prostate Cancerin Michigan Colorectal Cancerin Michigan Melanomain Michigan Leukemiain Michigan Lymphomain Michigan Pancreatic Cancerin Michigan Ovarian Cancerin Michigan Brain Cancerin Michigan Diabetes

Data from ClinicalTrials.govTerms

CompletedTrastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to TrastuzumabThe goal in this Phase 1 dose-escalation trial of the anti-IL-6R monoclonal antibody tocilizumab in combination with trastuzumab and pertuzumab in subjects with metastatic HER2…NCT03135171·Chicago, Illinois and 2 others

CompletedPaclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryThis randomized phase III trial studies paclitaxel and trastuzumab with or without lapatinib to see how well they work in treating patients with stage II or stage III breast…NCT00770809·Tucson, Arizona and 317 others

CompletedAn Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid TumorsThe purpose of the study is to assess the safety, tolerability and effectiveness of experimental medication BMS-986016 administered alone and in combination with nivolumab in…NCT01968109·La Jolla, California and 53 others

CompletedA Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's DiseaseThis is a open-label extension (OLE) study designed to evaluate the long-term efficacy, safety, and tolerability of Upadacitinib (ABT-494).NCT02782663·La Jolla, California and 60 others

UnknownEvaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant RejectionInduction therapy with antibodies is administered during transplant surgery and for a short period of time following transplant surgery in an effort to render the immune system…NCT01154387·Aurora, Colorado and 11 others

CompletedRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionThis phase I trial studies the side effects and best dose of romidepsin in treating patients with lymphoma, chronic lymphocytic leukemia, or solid tumors with liver dysfunction.NCT01638533·Duarte, California and 11 others

CompletedLessons Learned From the Family Gene ToolkitMutations in the BRCA1/2 genes are the primary cause of hereditary breast/ovarian cancer syndrome.NCT02154633·Ann Arbor, Michigan

CompletedA Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)The study is a Phase II randomized, open label, multicenter trial designed to identify whether sirolimus is a potential alternative to prednisone as an up-front treatment for…NCT02806947·Duarte, California and 20 others

CompletedMicrobiota Restoration Therapy for Recurrent Clostridium Difficile InfectionThis study will evaluate efficacy and safety information about RBX2660 for the treatment of recurrent Clostridium difficile infection (CDI), and will compare the efficacy of one…NCT02589847·Phoenix, Arizona and 29 others

CompletedA Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the LiverFC-6 is a Phase II, multi-center clinical trial for patients with unresectable, wild-type K-RAS, colorectal cancer with metastases confined to the liver.NCT00803647·Loma Linda, California and 22 others

TerminatedProspective Clinical Study of the Guidant Microwave Ablation System for the Treatment of PAF in the MIS ProcedureThe purpose of this prospective, single-arm, un-blinded, multi-site clinical study is to assess the safety and efficacy of the Microwave Ablation System for the treatment of…NCT00415558·Mesa, Arizona and 4 others

TerminatedPROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on ApixabanCurrently, warfarin is the only approved anticoagulation for patients with mechanical valves.NCT04142658·Tucson, Arizona and 61 others

CompletedZimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular DegenerationThe objectives of this study were to evaluate the safety and efficacy of Zimura intravitreal (IVT) administration when administered in participants with geographic atrophy (GA)…NCT02686658·Phoenix, Arizona and 77 others

RecruitingA Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)In this study, researchers will learn more about the use of felzartamab in participants with primary membranous nephropathy, also known as PMN.NCT06962800·Huntsville, Alabama and 116 others

No longer availableIntermediate-Sized Expanded Access StudyThis expanded access protocol is to provide access to the investigational product, SLS-005, to participants with ALS who are not eligible to participate in clinical trials.NCT05597436·Phoenix, Arizona and 20 others

CompletedPilot Study of Familial Nonsyndromal Mondini DysplasiaOBJECTIVES: I.NCT00004336·Ann Arbor, Michigan

WithdrawnA Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile SpasmsThe main purpose of this study is to evaluate the efficacy of AMZ002 compared to Vigabatrin in participants with newly diagnosed infantile spasms (IS).NCT05128344·Aurora, Colorado and 40 others

CompletedA Phase 1/2 Study of AEB1102 in Patients With Arginase I DeficiencyA Phase 1/2 Open-label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous AEB1102.NCT02488044·Stanford, California and 8 others

PreviousPage 168 of 1005Next

in Michigan

Heart Diseasein Michigan